InvestorsHub Logo
Followers 12
Posts 818
Boards Moderated 1
Alias Born 11/13/2019

Re: None

Wednesday, 07/19/2023 9:05:11 AM

Wednesday, July 19, 2023 9:05:11 AM

Post# of 8299
$TENX -Issued U.S. Patent for Oral Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
UP 4.8% Pre-Market/ Current Price $0.31
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TENX News